Yaqub Yahaya, Ejembi Joan, Aminu Aliyu, Daninna Zainab Rabilu, Tanko Zainab Lamido, Ibrahim Nasiru Usman, Audu Oduma, Ega Bawa
Medical Microbiology Department, Ahmadu Bello University Zaria, Kaduna State, Nigeria.
Medical Microbiology Department, Bayero University Kano, Kano State, Nigeria.
Int Health. 2025 Sep 3;17(5):769-777. doi: 10.1093/inthealth/ihaf026.
Multidrug-resistant organisms (MDROs) are important in clinical practice worldwide. As whole genome sequencing (WGS) technologies are adopted, it is key to understand the nature of MDROs before the introduction of WGS in resource-poor settings.
A hospital-based surveillance study was conducted in the largest referral health facility in northern Nigeria. A rectal swab sample was collected from each patient and samples were investigated for extended spectrum beta-lactamases and carbapenemase-resistant Enterobacterales (i.e. ESBL-PE and CRE, respectively). These MDROs were subjected to antimicrobial susceptibility testing and multiplex PCR. Statistical analyses were used to identify any associations between MDROs and selected antibiotics.
The prevalence of MDROs among participants (N=168) was 87.5% (n=147) for ESBL-PE and 4.2% (n=7) for CRE. All isolates were resistant to tetracycline and co-trimoxazole; however, most MDROs were susceptible to meropenem, ceftazidime-avibactam and fosfomycin (≥70%). blaSHV (33.3%; n=49) was the predominant ESBL gene carried by the isolates, followed by combinations of blaSHV, blaCTX and blaTEM. Although no carbapenemase genes were found, all CRE isolates had the blaOXA-48 gene, which may not be associated with phenotypic carbapenem resistance observed (χ2=0.056, p=0.81).
Research utilising WGS and bioinformatics will elucidate more of the molecular landscape of MDROs in resource-poor settings.
耐多药微生物(MDROs)在全球临床实践中都很重要。随着全基因组测序(WGS)技术的采用,在资源匮乏地区引入WGS之前了解MDROs的性质是关键。
在尼日利亚北部最大的转诊医疗机构进行了一项基于医院的监测研究。从每位患者采集直肠拭子样本,并对样本进行超广谱β-内酰胺酶和耐碳青霉烯类肠杆菌科细菌(即分别为ESBL-PE和CRE)检测。对这些MDROs进行药敏试验和多重PCR。采用统计分析来确定MDROs与所选抗生素之间的任何关联。
参与者(N = 168)中ESBL-PE的MDROs患病率为87.5%(n = 147),CRE为4.2%(n = 7)。所有分离株对四环素和复方新诺明耐药;然而,大多数MDROs对美罗培南、头孢他啶-阿维巴坦和磷霉素敏感(≥70%)。blaSHV(33.3%;n = 49)是分离株携带的主要ESBL基因,其次是blaSHV、blaCTX和blaTEM的组合。虽然未发现碳青霉烯酶基因,但所有CRE分离株都有blaOXA-48基因,这可能与观察到的表型碳青霉烯耐药性无关(χ2 = 0.056,p = 0.81)。
利用WGS和生物信息学的研究将阐明资源匮乏地区MDROs更多的分子格局。